The courses available here are in response to requests from many GPs for up to date evidence-based information and guidance in managing women’s midlife health issues including menopause.
The courses are available free online for AMS Members.
A Member Login needs to be obtained first.
Courses for the 2020-2022 triennium are now available
The workshop is aimed at all GPs, specialists and allied health workers who are seeking a comprehensive update in the field of menopause management.
RACGP Activity ID: 189797 Total Points 6
ACRRM ID: 19765
To access the course you will need a Member Login.
The workshop is aimed at all GPs, specialists and allied health workers who are seeking a comprehensive update in the field of menopause management.
RACGP Activity ID: 189800 Total Points 6
ACRRM ID: 19769
To access the course you will need a Member Login.
All major world menopause guidelines are now consistent with advice that MHT is appropriate treatment to offer to symptomatic healthy women “around the time of menopause”. This presentation will focus on the practicalities of the menopause consultation in 2018 and on how to approach the prescribing of MHT in an individual woman. How to choose, initiate and monitor the different forms of MHT will be discussed and will include the newer preparations of MHT available as options in Australia and New Zealand.
RACGP QI&CPD Program 2020-22 Triennium,
Activity ID: 189801 Total Points 1
ACRRM: Activity 20061 1 PDP
To access the course you will need a Member Login.
Many factors contribute to female sexual function, which changes with age and in the years surrounding menopause. Female sexual dysfunction is prevalent and associated with distressing symptoms that can challenge relationships and hamper quality of life and wellbeing. The most common type of female sexual dysfunction is lowered sexual desire. Contributing factors to female sexual dysfunction are highlighted, with a focus on those relevant to peri- and postmenopausal women. Assessment and management of women with female sexual dysfunction is discussed, including the role of menopausal hormone therapy, testosterone and other targeted treatments. New and emerging treatments are outlined.
RACGP QI&CPD Program 2020-22 Triennium,
Activity ID: 152985 Total Points 1 Category 2
ACRRM: Activity 20064 1 PDP
To access the course you will need a Member Login.
With the plentiful free press commentary on transvaginal mesh and tapes this session allows an excellent opportunity to review the management of female urinary incontinence.
We will review the management and referral pathway for GP on urinary incontinence released by the ACSQHC this year. We will also review diagnosis and management of urinary retention and algorithms for overactive bladder and SUI management.
RACGP QI&CPD Program 2020-22 Triennium,
Activity ID: 189798 Total Points 1 Category 2
ACRRM: Activity ID: 20065 1 PDP
To access the course you will need a Member Login.
Menopausal hormone therapy (MHT)
is an effective treatment that can be offered to most women with
menopausal symptoms, following an appropriate assessment and using a
shared decision-making process.
RACGP Activity No 189804 – Total Points 2
ACRRM ID: 19769 Class name: An Update on MHT - 05/03/2020 - 31/12/2022 - 1 Point
To access the course you will need a Member Login.
This is a case study of a patient seeking treatment for menopausal symptoms who has a history of fracture and venous thromboembolism (VTE). Joan is a 51 year old Caucasian woman who presents to you with menopausal symptoms of debilitating hot flushes, night sweats, and insomnia.
RACGP Activity No 180037 – Total Points 2.
ACCRM 2020-2022 Triennium Activity. ID: 19767 - 1 Point
To access the course you will need a Member Login.
The workshop is aimed at all GPs, specialists and allied health workers who are seeking a comprehensive update in the field of menopause management.
Activity ID: 171472 Total Points 6 Category 2
To access the course you will need a Member Login.
This presentation will focus on the practicalities of the menopause consultation in 2018 and on how to approach the prescribing of MHT in an individual woman. How to choose, initiate and monitor the different forms of MHT will be discussed and will include the newer preparations of MHT available as options in Australia and New Zealand.
To access the course you will need a Member Login.
This activity will review the management and referral pathway for GP on urinary incontinence released by the ACSQHC 2018, the diagnosis and management of urinary retention and algorithms for overactive bladder and SUI management. This presentation covers relevant issues for GPs.RACGP QI&CPD Program 2019-21 Triennium,
Activity ID: 152989 Total Points 1 Category 2
To access the course you will need a Member Login.